![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 46, 36263-36268, November 17, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Boston University School of Medicine, Boston, Massachusetts
02118
Received for publication, March 31, 2000, and in revised form, August 22, 2000
Although Glut4 traffic is routinely described as
translocation from an "intracellular storage pool" to the plasma
membrane, it has been long realized that Glut4 travels through at least two functionally distinct intracellular membrane compartments on the
way to and from the cell surface. Biochemical separation and systematic
studies of the individual Glut4-containing compartments have been
limited by the lack of appropriate reagents. We have prepared a
monoclonal antibody against a novel component protein of Glut4 vesicles
and have identified this protein as cellugyrin, a ubiquitously
expressed homologue of a major synaptic vesicle protein, synaptogyrin.
By means of sucrose gradient centrifugation, immunoadsorption, and
confocal microscopy, we have shown that virtually all cellugyrin is
co-localized with Glut4 in the same vesicles. However, unlike Glut4,
cellugyrin is not re-distributed to the plasma membrane in response to
insulin stimulation, and at least 40-50% of the total population of
Glut4 vesicles do not contain this protein. We suggest that cellugyrin
represents a specific marker of a functionally distinct population of
Glut4 vesicles that permanently maintains its intracellular
localization and is not recruited to the plasma membrane by insulin.
In fat, skeletal muscle, and heart, insulin causes massive
translocation of Glut4-containing membrane vesicles to the plasma membrane (1-6). Several lines of evidence suggest that Glut4 travels
through different intracellular membrane compartments during its
recycling to and from the cell surface. First, Slot et al.
(7, 8) showed by immunoelectron microscopy that intracellular Glut4
resides in different types of membrane structure. Second, the results
of the mathematical analysis of Glut4 traffic are inconsistent with the
existence of only one intracellular pool of Glut4, suggesting that
there may be two or more distinct intracellular Glut4-containing
compartments (9). Third, the analysis of targeting sequences in the
Glut4 molecule lead to a three-pool model of Glut4 recycling (one
plasma membrane pool and two intracellular pools) (10). Fourth,
ablation of recycling endosomes with HRP1-conjugated
transferrin resulted in only partial removal
of Glut4 (11, 12), suggesting that Glut4 is present in recycling
endosomes as well as in an unidentified separate compartment. Finally,
biochemical separation of two (13) or even three (14) intracellular
Glut4-containing compartments has recently been reported.
The nature of these multiple compartments is not completely understood.
One of them, however, has been identified as early/sorting endosomes
(7, 11, 12), and another may represent specialized post-endosomal
insulin-responsive vesicles, or IRV (10-14). Mainly because of the
lack of appropriate reagents, neither compartment has ever been
purified and systematically studied, and therefore it is not clear what
the biochemical difference between them may be.
To identify proteins that reside in different populations of Glut4
vesicles and may thus be used as specific protein markers for
individual Glut4-containing compartments, we prepared monoclonal antibodies against several peripheral membrane proteins of Glut4 vesicles. We selected a hybridoma producing a monoclonal antibody against p28, a protein that has previously not been detected in Glut4
vesicles. Using this antibody, we immunopurified this protein from
intracellular microsomes and identified it as cellugyrin by proteolytic
digestion and mass spectrometry. This result was confirmed by
expression of the cellugyrin cDNA (15) in COS cells. Cellugyrin
represents a ubiquitous homologue of synaptogyrin (16), a major
constituent of synaptic vesicles that is involved in regulation of
exocytosis in PC12 cells (17). In rat adipocytes, at least 90% of
cellugyrin is localized in Glut4-containing vesicles, whereas only
50-60% of Glut4 vesicles contain this protein. Unlike Glut4, cellugyrin is not redistributed to the plasma membrane in response to
insulin stimulation. These data strongly indicate that intracellular Glut4-containing vesicles are not homogenous but represent a
mixture of at least two individual populations: cellugyrin-negative
vesicles, which are recruited to the cell surface in response to
insulin stimulation; and cellugyrin-positive vesicles, which are not
translocated by insulin. Interestingly, cellugyrin-positive vesicles
are enriched with SCAMPs and VAMP2 and practically lack
VAMP3/cellubrevin.
Materials--
In the present study, we used monoclonal
anti-Glut4 antibody 1F8 (18) for Western blotting and anti-Glut4 rabbit
serum (19) (a kind gift of Dr. Giulia Baldini, Columbia University, New
York) for immunofluorescent staining. Anti-IRAP rabbit serum was a kind gift of Dr. P. Pilch, Boston University School of Medicine, Boston, MA.
Anti-cellubrevin rabbit serum was a kind gift of S. Olken and Dr. R. Corley, Boston University School of Medicine. DEAE-cellulose purified
anti-IGF-II/man 6-P receptor polyclonal antibody was a kind gift of Dr.
M. Czech, University of Massachusetts Medical School, Worcester, MA.
Rabbit anti-serum against sortilin was prepared by Quality Controlled
Biochemicals, Inc., Hopkinton, MA using the peptide
ac-CFGQSKLYRSEDYGKNFKD-amide (amino acids 17-34) as antigen.
Monoclonal antibody against SCAMPs was described earlier (20). The
monoclonal anti-transferrin receptor antibody was from
Zymed Laboratories Inc., monoclonal anti-VAMP2
antibody was from Synaptic Systems. The rat cellugyrin cDNA in the
pCMV5 expression vector was a kind gift of Dr. Thomas
Südhof, Southwestern Medical Center at Dallas, TX.
Preparation, Isotyping, and Purification of a Monoclonal Antibody
against p28--
Glut4-containing vesicles were immunoisolated from
rat adipocytes on acrylic immunobeads as described below and used for
intraperitoneal injection of BALB/c mice according to the protocol
described by Thoidis et al. (20) but without adjuvant. Mice
were injected with the same amount of material (vesicles isolated from
0.5 mg of light microsomes (LM) on 0.2 ml of 1F8-beads) 4 times with 3-week intervals. The fusion of spleenocytes with SP2/0 mouse myeloma cells (2 spleen cells/1 myeloma cell) was performed 4 days
after the final boost. The supernatants from resulting hybridomas were
screened in a Mini-PROTEAN II multiscreen apparatus (Bio-Rad) by
Western blotting using sucrose gradient-enriched (see below) and/or
immunoisolated Glut4-containing vesicles. A positive hybridoma selected
for this study was cloned by limiting dilution. Hybridoma culture
supernatant was isotyped with the help of the Sigma ImmunoType kit
(ISO-1), and the anti-p28 antibody was classified as IgG2a. This
antibody was purified from the tissue culture supernatant on
immobilized protein A with the help of ImmunoPure (A) IgG Purification Kit (Pierce). In parallel, nonspecific mouse IgG were purified from
mouse serum (Sigma). The purity of the isolated immunoglobulins was
confirmed by SDS-electrophoresis and Coomassie staining.
Transfection of COS Cells--
The rat cellugyrin cDNA was
transfected into COS cells (4 µg of cDNA/100-mm dish) using
LipofectAMINE PLUS reagent (Life Technologies, Inc.) according to the
manufacturer's instructions. Dulbecco's modified Eagle's medium with
20% fetal bovine serum (5 ml) was added 3-5 h after transfection;
10% fetal bovine serum in Dulbecco's modified Eagle's medium
was substituted the next day. Cells were harvested 48 h after
transfection, lysed with 1 ml of extraction buffer (Tris-buffered
saline with 1% Triton X-100, 1 µg/ml leupeptin, 1 µg/ml aprotinin,
1 µg/ml pepstatin, 1 µg/ml aprotinin, and 1 mM
phenylmethanesulfonyl fluoride) for 10-15 min on ice, and microfuged for 5 min. The supernatant was analyzed by Western blot.
Isolation of p28 from Rat Liver Microsomes--
A microsomal
membrane fraction was isolated from rat liver according to
Fleischer and Kervina (21). The microsomal pellet (40 mg) was
solubilized in PBS with protease inhibitors and 1% Triton X-100 for
4 h at 4 °C, centrifuged at 15,000 rpm for 30 min, and
pre-cleared with nonspecific IgG coupled to acrylic beads. The
resulting supernatant was incubated with 1 ml of anti-p28 immunobeads
in a total volume of 10 ml overnight at 4 °C on a rotator.
Immunobeads were then transferred to the column and washed with 15 ml
of 10 mM phosphate buffer, pH 6.8. Elution was carried out
with 100 mM glycine, pH 2.5; three 3-ml fractions were
collected. Eluted proteins were precipitated with three volumes of cold
ethanol overnight at Isolation and Fractionation of Rat Adipocytes--
Adipocytes
were isolated from the epididymal fat pads of male Harlan
Sprague-Dawley rats (150-175 g) by collagenase digestion and
transferred to KRP buffer (12.5 mM HEPES, 120 mM NaCl, 6 mM KCl, 1.2 mM
MgSO4, 1 mM CaCl2, 0.6 mM Na2HPO4, 0.4 mM
NaH2PO4, 2.5 mM
D-glucose, 2% bovine serum albumin, pH 7.4). Insulin was administered to cells (where indicated) to a final concentration of 10 nM for 15 min, after which KCN was added to cells to a
final concentration 2 mM for 5 min, and cells were washed
3-4 times with HES buffer cooled to 14-16 °C (20 mM
HEPES, 250 mM sucrose, 1 mM EDTA, 5 mM benzamidine, 1 mM phenylmethanesulfonyl
fluoride, 1 µM pepstatin, 1 µM aprotinin, 1 µM leupeptin, pH 7.4), homogenized with a Potter-Elvehjem
Teflon pestle, and subcellular fractions prepared as described
previously (23).
Preparation of Tissue Extracts--
Rat tissues were excised and
immediately homogenized in a Polytron homogenizer at 13,500 rpm in HES
buffer on ice. The homogenate was centrifuged for 10 min at
1500 × g and the pellet discarded. The resulting
supernatant was analyzed by SDS-electrophoresis and Western blotting
with anti-cellugyrin antibodies.
Fractionation of Intracellular Microsomes in Sucrose Velocity
Gradients--
Light and heavy microsomes (LM and HM) from rat
adipocytes, suspended in PBS (150-200 µl) with protease inhibitors,
were loaded on 4.6-ml 10-30% continuous sucrose gradients (in PBS)
and centrifuged at 48,000 rpm in a Beckman SW-50.1 rotor for 55 min at
4 °C. Membranes from the gradients were collected into 23-30
fractions starting from the bottom of the tubes. The protein
concentration and refractive index were measured in aliquots. The
position of Glut4- and cellugyrin-containing vesicles was determined by
Western blotting of the gradient fractions. All high speed
centrifugations were performed in a Sorvall Discovery 90 ultracentrifuge.
Immunoadsorption of Glut4- and Cellugyrin-containing
Vesicles--
Protein A-purified 1F8 antibody, anti-cellugyrin
antibody, and nonspecific mouse IgG were each coupled to acrylic beads
(Reacti-gel GF 2000, Pierce) at a concentration of 0.90, 2.0, and 0.91 mg/ml of antibody/ml of resin, respectively, according to the
manufacturer's instructions. Before usage, the beads were saturated
with 2% bovine serum albumin in PBS for at least 1 h and washed
with PBS. LM from rat adipocytes were incubated separately with each of
the specific and nonspecific antibody-coupled beads overnight at
4 °C. The beads were washed 5 times with PBS, and the adsorbed
material was subsequently eluted with 1% Triton X-100 in PBS and
Laemmli sample buffer without reductants in order to avoid dissociation of the coupled antibodies.
Immunofluorescent Staining--
Isolated rat adipocytes were
fixed and stained according to Malide et al. (24). Briefly,
cells were fixed with 4% paraformaldehyde in PBS, pH 7.4, for 20 min
at room temperature, washed 3 times with PBS, permeabilized with 0.1%
Triton X-100 in PBS for 15 min at room temperature, and blocked with
blocking solution (3% normal donkey serum and 1% bovine serum
albumin) for 1 h at room temperature. The cells were stained with
anti-cellugyrin antibodies (10 µg/ml) and fluorescein
isothiocyanate-conjugated donkey anti-mouse IgG (Jackson
ImmunoResearch, 1:200) and then with polyclonal anti-Glut4 rabbit serum
(1:1000) and Cy3-conjugated donkey anti-rabbit IgG (Jackson
ImmunoResearch, 1:100). All dilutions of antibodies were done with the
blocking solution. Each incubation with primary or secondary antibody
lasted 1 h at room temperature. SlowFade-Light Antifade kit
(Molecular Probes) was used for mounting cells on slides. Staining was
examined using a confocal laser scanning microscope (Zeiss LSM 510).
Gel Electrophoresis and Immunoblotting--
Proteins were
separated in SDS-polyacrylamide gels according to Laemmli (22), but
without reducing agents, and were transferred to Immobilon-P membrane
(Millipore) in 25 mM Tris, 192 mM glycine. Following transfer, the membrane was blocked with 10% nonfat dry milk
in PBS for 2 h at 37 °C. Proteins were visualized with specific antibodies, HRP-conjugated secondary antibodies (Sigma), and an enhanced chemiluminescent substrate kit (PerkinElmer Life
Sciences). Autoradiograms were quantitated in a computing
densitometer (Molecular Dynamics).
Protein Content--
Protein content was determined with the BCA
kit (Pierce) according to the manufacturer's instructions.
Glut4 vesicles were immunoadsorbed from intracellular light
microsomes, or LM (1 mg) with 0.2 ml of 1F8-beads as described previously (25-30). This material was injected intraperitoneally into
each of four mice for 3 times every 3-4 weeks. Hybridoma-producing anti-p28 antibody was selected and cloned. This antibody was purified from the tissue culture supernatant on immobilized protein A, coupled
to acrylic beads, and used for immunoisolation of p28 from rat liver
microsomes as described under "Experimental Procedures." The
presence of cellugyrin in the isolated material was determined by Dr.
W. Lane and associates by proteolytic digestion and mass spectrometry.
To confirm this result, we expressed the rat cellugyrin cDNA (a
kind gift of Dr. T. Südhof) in COS-7 cells, which have virtually
no endogenous cellugyrin (15). Fig. 1
demonstrates that our anti-p28 monoclonal antibody recognizes the
recombinant protein, which strongly suggests that p28 is indeed
cellugyrin.
We also analyzed the expression of p28 in different rat tissues using
our antibody. We found that this protein is present in every tissue
studied with the exception of brain, which completely matches the
tissue expression pattern of cellugyrin (15, 31) and confirms that p28
represents a ubiquitously expressed analogue of the brain-specific
protein synaptogyrin (data not shown).
To study the intracellular localization of cellugyrin in rat
adipocytes, we fractionated these cells according to Simpson et
al. (23) and determined, by Western blotting, the cellugyrin content in different subcellular fractions (Fig.
2). In both basal and insulin-stimulated
adipocytes, cellugyrin is readily detectable only in LM and HM
fractions (Fig. 2). Longer exposures of the film allow detection of this protein in the plasma membrane, where the
specific content of cellugyrin is much lower than in intracellular HM
and LM (not shown), which may be explained by cross-contamination between the fractions. In these experiments, we did not detect any
significant redistribution of cellugyrin between subcellular fractions
in response to insulin stimulation.
Cellugyrin Is a Marker for a Distinct Population of Intracellular
Glut4-containing Vesicles*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C, pelleted at 15,000 rpm for 30 min,
solubilized in 200 µl of Laemmli sample buffer (22), and separated by
SDS-electrophoresis. The gel was stained with freshly prepared
Coomassie Brilliant Blue R-250. Three distinct protein bands were
detected in the 25-30-kDa area. All of these bands were cut out from
the gel along with a similar slice of the nonstained gel used for
background setting. Each gel slice was split into two non-equal parts.
The major part (about two-thirds of each slice) was washed with 50% acetonitrile (HPLC grade, Fisher) and stored at
70 °C. The smaller part of each gel slice was washed several times with deionized water,
chopped, and extracted with Laemmli sample buffer overnight at room
temperature, and the extracted material was electrophoresed. The gel
slice that contained p28 was identified by Western blotting and
submitted for sequence analysis to the Harvard Microchem laboratory. The presence of cellugyrin was determined in this material by Dr. W. Lane and associates by proteolytic digestion and mass spectrometry.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 1.
Anti-p28 antibody recognizes recombinant
cellugyrin. The rat cellugyrin cDNA in the pCMV5 expression
vector was transfected into COS cells as described under
"Experimental Procedures," and the total extract from transfected
(+) and nontransfected (
) cells (25 and 50 µg, respectively)
along with rat LM (100 µg) was analyzed by Western blotting 48 h
later.

View larger version (53K):
[in a new window]
Fig. 2.
Subcellular distribution of Glut4 and
cellugyrin. Rat adipocytes treated (+) and not treated (
) with
insulin were fractionated into subcellular fractions by differential
centrifugation as described under "Experimental Procedures." The
figure demonstrates Western blot of each fraction (50 µg). Both
proteins were visualized by consecutive staining of the same membrane.
A representative result of five independent experiments is shown.
M/N, mitochondria/nuclei; Cyt., cytosol.

View larger version (68K):
[in a new window]
Fig. 3.
Sucrose block of endocytosis does not lead to
the accumulation of cellugyrin in the plasma membrane. The figure
demonstrates Western blot of membrane fractions (50 µg) isolated from
insulin-treated and untreated adipocytes incubated in the absence or in
the presence of 0.45 M sucrose for 30 min at 37 °C. All
proteins were visualized by consecutive staining of the same membrane.
A representative result of three independent experiments is shown.
TfR, transferrin receptor.
The apparent absence of cellugyrin in the plasma membrane may have two explanations. First, cellugyrin may be a truly intracellular protein that is not recruited to the plasma membrane even in the presence of insulin. Second, cellugyrin may rapidly recycle between the plasma membrane and its intracellular compartment but with an internalization rate so high that cellugyrin is not accumulated at the plasma membrane in any detectable quantities. To discriminate between these two possibilities, we blocked clathrin-mediated endocytosis in adipocytes by sucrose as described previously by Hansen et al. (32). As seen in Fig. 3, incubation of cells at 37 °C for 30 min in 0.45 M sucrose leads to the accumulation of recycling proteins, such as the transferrin receptor and Glut4, in the plasma membrane. However, only traces of cellugyrin can be detected in this fraction under all experimental conditions. A similar result was obtained upon inhibition of clathrin-mediated endocytosis by potassium depletion (32) (results not shown); this suggests that cellugyrin is localized mainly in intracellular membranes both in the absence and presence of insulin.
To further explore the intracellular localization of cellugyrin,
we carried out sucrose gradient
centrifugation of LM and HM fractions (Fig. 4). We found that
cellugyrin is present in rather homogenous vesicles, which are very
well separated from the total microsomal protein (not shown) and
demonstrate a high degree of overlap with Glut4-containing vesicles in
both insulin-treated and nontreated cells.
|
The aim of the following experiments was to confirm co-localization of
cellugyrin with Glut4 by immunoadsorption. As seen in Fig.
5, anti-Glut4 antibody 1F8 can efficiently
immunoadsorb cellugyrin from the LM (and also HM, not shown) fraction.
As expected, cellugyrin can be eluted from 1F8-beads with Triton X-100,
whereas Glut4 is resistant to Triton elution and can be removed from
the beads only with SDS-containing sample buffer. We estimated by densitometry of autoradiograms that at least 90% of the total p28 in
LM is localized in Glut4 vesicles. For example, when 50 µg of LM were
taken for 50 µl of 1F8-beads (Fig. 5, lane 1), we were
able to immunoadsorb 91% of the total Glut4 and 85% of total cellugyrin. When we increased the amount of LM for the same volume of
beads (lanes 2 and 3), their binding capacity was
exceeded, and some Glut4 vesicles did not bind to the beads. Under all
conditions, however, we immunoadsorbed identical fractions of Glut4 and
cellugyrin. However, when we carried out immunoadsorption with
anti-cellugyrin immunobeads, we were able to bring down only about
50-60% of Glut4-containing membranes (Fig.
6). We suggest, therefore, that cellugyrin is present only in a sub-population of Glut4-containing vesicles.
|
|
This result was confirmed by double-immunofluorescent staining of Glut4
and cellugyrin in rat adipocytes. With the help of confocal microscopy
(Fig. 7), we show that a high degree of
co-localization exists between cellugyrin and Glut4 in these cells. It
is seen in Fig. 7, however, that although virtually all cellugyrin is co-localized with Glut4, a significant fraction of Glut4-containing membranes (about 40-50%) does not contain cellugyrin, which is consistent with the results of the immunoadsorption experiments. Interestingly, the middle section of Fig. 7 shows that Glut4-positive cellugyrin-negative vesicles are located closer to the cell surface than vesicles that contain both proteins. This observation may support
indirectly the results of the subcellular fractionation (Figs. 2 and
3), which shows virtually no redistribution of cellugyrin to the plasma
membrane in response to insulin.
|
We have found that all major recycling proteins previously found in
Glut4 vesicles, such as IRAP, sortilin, receptors for transferrin, and
IGFII/man 6-P are present in cellugyrin-containing vesicles (Fig.
8). Unexpectedly, it turned out that
cellugyrin-positive vesicles are enriched in SCAMPs and VAMP2 but do
not have (or have only traces of) VAMP3 (cellubrevin). In agreement
with these data, VAMP3 is translocated to the cell surface in response
to insulin to a greater extent than SCAMPs and VAMP2 (Fig.
9; see also Refs. 33 and 20). These results
are consistent with the earlier observation that VAMP2 and VAMP3 are
localized in different vesicular populations (33) and may or may not
indicate that in rat adipocytes, VAMP3 rather than VAMP2 plays the role
of the v-SNARE in the process of Glut4 vesicle fusion with the
plasma membrane. Other studies performed in 3T3-L1 adipocytes (12, 34)
and in L6 myoblasts (35) suggest, however, that VAMP2 is the v-SNARE in
Glut4 vesicles. We believe that more experiments are required to
determine the functions of VAMP isoforms in individual populations of
Glut4 vesicles.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
We have developed a monoclonal antibody against a previously unknown protein in Glut4 vesicles and have identified this protein as cellugyrin, a homologue of a major synaptic vesicle protein, synaptogyrin. Synaptogyrin, a four-transmembrane protein, is distantly related to synaptophysin (16) and represents one of the most abundant proteins in synaptic vesicles. Its biological functions are not exactly clear. In a recent report, exogenously expressed synaptogyrin was shown to potently and specifically inhibit Ca2+-dependent exocytosis from PC12 cells (17). Knock-out experiments, however, have not revealed major biochemical changes in neurotransmitter release but have shown severely reduced short term and long term synaptic plasticity (36).
In fat cells (and also in skeletal and cardiomyocytes; not shown), virtually all cellugyrin is co-localized with Glut4. However, about 40-50% of Glut4 vesicles do not contain cellugyrin. Moreover, we have not detected any significant redistribution of cellugyrin to the plasma membrane in response to insulin stimulation; this suggests that cellugyrin may, in fact, be present only in a distinct population of Glut4 vesicles with unique and specific properties. The possibility should be acknowledged that some Glut4 vesicles lack cellugyrin simply because its level of expression is low, so that not all Glut4 vesicles may have a copy of this protein. For the following reasons, however, we believe that cellugyrin-positive vesicles represent a distinct and independent compartment in adipose cells. First, their functional properties are different, because these vesicles are not translocated to the plasma membrane (Figs. 2 and 3). Second, cellugyrin-positive vesicles have unique and specific protein composition. We have shown that in addition to cellugyrin, these vesicles compartmentalize a significant fraction of Glut4-associated SCAMPs and VAMP2 and have no (or only traces of) VAMP3 (Fig. 8).
The majority of previously obtained results are consistent with the hypothesis that the total pool of intracellular Glut4 is distributed between early/sorting endosomes and putative post-endosomal vesicles that are recruited to the cell surface in response to insulin (see the Introduction). Based on our data, it seems logical to propose that cellugyrin may be localized specifically in the former compartment. Because Glut4 constantly recycles to and from the cell surface both in the absence and in the presence of insulin (37-39), its transition through the endosomal compartment should be accelerated by insulin. This, by the way, may be illustrated by Fig. 8, which shows that the amount of recycling proteins, such as the IGFII/man 6-P receptor, the transferrin receptor, IRAP, sortilin, and Glut4 itself, is significantly decreased in cellugyrin-positive vesicles after insulin administration. We believe, therefore, that the Glut4-containing endosomal compartment, although not translocatable directly to the plasma membrane, may still respond to insulin stimulation in as yet unknown fashion.
It was also suggested that intracellular Glut4 may be present not only
in the endosomal compartments but in the trans-Golgi network as
well (3). Others, however, have not detected trans-Golgi network
markers in Glut4 vesicles (40, 41). The possibility still remains that
cellugyrin-positive vesicles may represent a fraction of the
trans-Golgi network; we will try to determine the cell biological
nature of the individual Glut4-containing compartments in the near future.
| |
ACKNOWLEDGEMENTS |
|---|
we thank He-Jin Lee and Vera Kandror for help with several experiments; Dr. Galini Thoidis for helpful advice, discussions, and critical reading of the manuscript; and Drs. T. Sudhof, D. Kedra, G. Baldini, S. Olken, and R. Corley for the generous gifts of the reagents.
| |
FOOTNOTES |
|---|
* This work was supported by NIDDK, National Institutes of Health Pilot Research Grant P30 DK46200 from Boston Obesity and Nutrition Research Center (to T. A. K.), by National Institutes of Health Research Grants DK52057 and DK56736, and by a research grant from the American Diabetes Association (to K. V. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry,
Boston University School of Medicine, K121 715 Albany St., Boston, MA
02118. Tel.: 617-638-5049; Fax: 617-638-5339; E-mail: kandror@biochem.bumc.bu.edu.
Published, JBC Papers in Press, August 30, 2000, DOI 10.1074/jbc.M002797200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HRP, horseradish peroxidase; SCAMP, secretory carrier-associated membrane protein; VAMP, vesicle-associated membrane protein; IRAP, insulin-regulated aminopeptidase; v-SNARE, vesicle-soluble N-ethylmaleimide-sensitive factor-attachment protein receptor; LM, light microsomes; HM, heavy microsomes; PBS, phosphate-buffered saline.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Birnbaum, M. J. (1992) Int. Rev. Cytol. 137A, 239-297 |
| 2. | Kahn, B. B. (1992) J. Clin. Invest. 89, 1367-1374 |
| 3. | Rea, S., and James, D. E. (1997) Diabetes 46, 1667-1677 |
| 4. | Kandror, K. V., and Pilch, P. F. (1996) Am. J. Physiol. 271, E1-E14 |
| 5. | Czech, M. P., and Corvera, S. (1999) J. Biol. Chem. 274, 1865-1868 |
| 6. | Pessin, J. E., Thurmond, D. C., Elmendorf, J. S., Coker, K. J., and Okada, S. (1999) J. Biol. Chem. 274, 2593-2596 |
| 7. | Slot, J. W., Geuze, H. J., Gigengack, S., Lienhard, G. E., and James, D. E. (1991) J. Cell Biol. 113, 123-135 |
| 8. | Slot, J. W., Geuze, H. J., Gigengack, S., James, D. E., and Lienhard, G. E. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7815-7819 |
| 9. | Holman, G. D., Leggio, L. L., and Cushman, S. W. (1994) J. Biol. Chem. 269, 17516-17524 |
| 10. | Verhey, K. J., Yeh, J.-I., and Birnbaum, M. J. (1995) J. Cell Biol. 130, 1071-1079 |
| 11. | Livingstone, C., James, D. E., Rice, J. E., Hanpeter, D., and Gould, G. W. (1996) Biochem. J. 315, 487-495 |
| 12. | Martin, S., Tellam, J., Livingstone, C., Slot, J. W., Gould, G. W., and James, D. E. (1996) J. Cell Biol. 134, 625-635 |
| 13. | Hashiramoto, M., and James, D. E. (2000) Mol. Cell. Biol. 20, 416-427 |
| 14. | Lee, W., Ryu, J., Souto, R. P., Pilch, P. F., and Jung, C. Y. (1999) J. Biol. Chem. 274, 37755-37762 |
| 15. | Janz, R., and Sudhof, T. C. (1998) J. Biol. Chem. 273, 2851-2857 |
| 16. | Stenius, K., Janz, R., Sudhof, T. C., and Jahn, R. (1995) J. Cell Biol. 131, 1801-1809 |
| 17. | Sugita, S., Janz, R., and Sudhof, T. C. (1999) J. Biol. Chem. 274, 18893-18901 |
| 18. | James, D. E., Brown, R., Navarro, J., and Pilch, P. F. (1988) Nature 333, 183-185 |
| 19. | Baldini, G., Hohman, R., Charron, M., and Lodish, H. F. (1991) J. Biol. Chem. 266, 4037-4040 |
| 20. | Thoidis, G., Kotliar, N., and Pilch, P. F. (1993) J. Biol. Chem. 268, 11691-11696 |
| 21. | Fleischer, S., and Kervina, M. (1974) Methods Enzymol. 31, 3-41 |
| 22. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 23. | Simpson, I. A., Yver, D. R., Hissin, P. J., Wardzala, L. J., Karnieli, E., Salans, L. B., and Cushman, S. W. (1983) Biochim. Biophys. Acta 763, 393-407 |
| 24. | Malide, D., Dwyer, N. K., Blanchette-Mackie, E. J., and Cushman, S. W. (1997) J. Histochem. Cytochem. 45, 1083-1096 |
| 25. | Kandror, K. V., and Pilch, P. F. (1994) J. Biol. Chem. 269, 138-142 |
| 26. | Kandror, K. V., and Pilch, P. F. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8017-8021 |
| 27. | Kandror, K. V., L. Yu, and Pilch, P. F. (1994) J. Biol. Chem. 269, 30777-30780 |
| 28. | Kandror, K. V., and Pilch, P. F. (1998) Biochem. J. 331, 829-835 |
| 29. | Lin, B.-Z., Pilch, P. F., and Kandror, K. V. (1997) J. Biol. Chem. 272, 24145-24147 |
| 30. | Kupriyanova, T. A., and Kandror, K. V. (1999) J. Biol. Chem. 274, 1458-1464 |
| 31. | Kedra, D., Pan, H.-Q., Seroussi, E., Fransson, I., Guilbaud, C., Collins, J. E., Dunham, I., Blennow, E., Roe, B. A., Piehl, F., and Dumanski, J. P. (1998) Hum. Genet. 103, 131-141 |
| 32. | Hansen, S. H., Sandvig, K., and vanDeurs, B. (1993) J. Cell Biol. 121, 61-72 |
| 33. | Volchuk, A., Sargeant, R., Sumitani, S., Liu, Z., He, L., and Klip, A. (1995) J. Biol. Chem. 270, 8233-8240 |
| 34. | Martin, L. B., Shewan, A., Milar, C. A., Gould, G. W., and James, D. E. (1998) J. Biol. Chem. 273, 1444-1452 |
| 35. | Randhawa, V. K., Bilan, P. J., Khayat, Z. A., Daneman, N., Liu, Z., Ramlal, T., Volchuk, A., Peng, X.-R., Coppola, T., Regazzi, R., Trimble, W. S., and Klip, A. (2000) Mol. Biol. Cell 11, 2403-2417 |
| 36. | Janz, R., Sudhof, T. C., Hammer, R. E., Unni, V., Siegelbaum, S. A., and Bolshakov, V. Y. (1999) Neuron 24, 687-700 |
| 37. | Jhun, B. H., Rampal, A. L., Liu, H., Lachaal, M., and Jung, C. Y. (1992) J. Biol. Chem. 267, 17710-17715 |
| 38. | Satoh, S., Nishimura, H., Clark, A. E., Kozka, I. J., Vanucci, S. J., Simpson, I. A., Quon, M. J., Cushman, S. W., and Holman, G. D. (1993) J. Biol. Chem. 268, 17820-17829 |
| 39. | Czech, M. P., and Buxton, J. M. (1993) J. Biol. Chem. 268, 9187-9190 |
| 40. | Martin, S., Reaves, B., Banting, G., and Gould, G. W. (1994) Biochem. J. 300, 743-749 |
| 41. | Bogan, J. S., and Lodish, H. F. (1999) J. Cell Biol. 146, 609-620 |
This article has been cited by other articles:
![]() |
J. Shi and K. V. Kandror The Luminal Vps10p Domain of Sortilin Plays the Predominant Role in Targeting to Insulin-responsive Glut4-containing Vesicles J. Biol. Chem., March 23, 2007; 282(12): 9008 - 9016. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, G. Huang, and K. V. Kandror Phosphatidylinositol 4-Kinase Type II{alpha} Is Targeted Specifically to Cellugyrin-Positive Glucose Transporter 4 Vesicles Mol. Endocrinol., November 1, 2006; 20(11): 2890 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsui, T. Nagoshi, E.-G. Hong, I. Luptak, K. Hartil, L. Li, N. Gorovits, M. J. Charron, J. K. Kim, R. Tian, et al. Effects of chronic Akt activation on glucose uptake in the heart Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E789 - E797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bose, A. Guilherme, S. Huang, A. C. Hubbard, C. R. Lane, N. A. Soriano, and M. P. Czech The v-SNARE Vti1a Regulates Insulin-stimulated Glucose Transport and Acrp30 Secretion in 3T3-L1 Adipocytes J. Biol. Chem., November 4, 2005; 280(44): 36946 - 36951. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Li and K. V. Kandror Golgi-Localized, {gamma}-Ear-Containing, Arf-Binding Protein Adaptors Mediate Insulin-Responsive Trafficking of Glucose Transporter 4 in 3T3-L1 Adipocytes Mol. Endocrinol., August 1, 2005; 19(8): 2145 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, J.-k. Kim, Y. Li, J. Li, F. Liu, and X. Chen Tannic Acid Stimulates Glucose Transport and Inhibits Adipocyte Differentiation in 3T3-L1 Cells J. Nutr., February 1, 2005; 135(2): 165 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Abel, C. Graveleau, S. Betuing, M. Pham, P. A. Reay, V. Kandror, T. Kupriyanova, Z. Xu, and K. V. Kandror Regulation of Insulin-Responsive Aminopeptidase Expression and Targeting in the Insulin-Responsive Vesicle Compartment of Glucose Transporter Isoform 4-Deficient Cardiomyocytes Mol. Endocrinol., October 1, 2004; 18(10): 2491 - 2501. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malikova, J. Shi, and K. V. Kandror V-type ATPase is involved in biogenesis of GLUT4 vesicles Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E547 - E552. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Belfort and K. V. Kandror Cellugyrin and Synaptogyrin Facilitate Targeting of Synaptophysin to a Ubiquitous Synaptic Vesicle-sized Compartment in PC12 Cells J. Biol. Chem., November 28, 2003; 278(48): 47971 - 47978. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu and K. V. Kandror Translocation of Small Preformed Vesicles Is Responsible for the Insulin Activation of Glucose Transport in Adipose Cells. EVIDENCE FROM THE IN VITRO RECONSTITUTION ASSAY J. Biol. Chem., December 6, 2002; 277(50): 47972 - 47975. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Kupriyanova, V. Kandror, and K. V. Kandror Isolation and Characterization of the Two Major Intracellular Glut4 Storage Compartments J. Biol. Chem., March 8, 2002; 277(11): 9133 - 9138. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||